Market Tracker

01/16 1:05pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

86.92
Delayed Data
As of Jan 13
 +0.76 / +0.88%
Today’s Change
62.12
Today|||52-Week Range
102.49
+4.93%
Year-to-Date

Today’s Trading

Previous close86.16
Today’s open86.16
Day’s range85.91 - 88.13
Volume1,037,735
Average volume (3 months)1,268,581
Market cap$14.9B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-16.30%
Earnings growth (this year)-246.63%
Earnings growth (next 5 years)+26.50%
Revenue growth (last year)+16.29%
P/E ratioNM
Price/Sales19.22
Price/Book5.85

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-0.38-0.49%
MYLMylan NV-0.04-0.11%
VRTXVertex Pharmaceutica...+0.78+0.95%
ALKSAlkermes Plc+0.81+1.48%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$872.2M
Annual profit (last year)-$171.8M
Net profit margin-19.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts